page contents

Additional Real-World Data Show a Significant Risk Increase in Cardiovascular Events in People with Elevated Triglyceride Levels Nasdaq:AMRN

(MENAFN – GlobeNewsWire – Nasdaq) itemprop=”articleBody”>BEDMINSTER, N.J. and DUBLIN, Ireland, March 18, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN ), a pharmaceutical company focused on improving cardiovascular health, announced today that real-world data reported by the U.S. Veteran’s Administration supports that patients with elevated triglyceride (TG) levels, despite statin therapy, had a significant 19% relative risk increase in a composite of cardiovascular events during a follow-up period of up to five years. These findings are consistent with previous observational, real-world, epidemiological, and genetic data that have consistently found a…
Nasdaq Search Results

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.